Rockwell Medical (RMTI) Adds Raymond Pratt, M.D., as Chief Medical Officer
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Join SI Premium – FREE
Rockwell Medical (Nasdaq: RMTI) has hired Raymond Pratt, M.D., as Chief Medical Officer. Dr. Pratt will oversee the clinical development and FDA regulatory process for Rockwell's Soluble Ferric Pyrophosphate (SFP) and manage all aspects of clinical research and development for SFP and new drug indications.
Prior to joining Rockwell, Dr. Pratt worked at Shire (Nasdaq: SHPGY) Pharmaceutical Development from 2003-2010, as Vice President R&D and the Scientific leader in the Emerging Business Unit and Renal Business Unit.
Prior to joining Rockwell, Dr. Pratt worked at Shire (Nasdaq: SHPGY) Pharmaceutical Development from 2003-2010, as Vice President R&D and the Scientific leader in the Emerging Business Unit and Renal Business Unit.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Getty Realty discloses separation terms for departing accounting officer
- LSI Industries CFO to retire in 2027, successor search underway
- Skyward Group CFO to retire in 2027, successor named
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
